Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -10.59 % |
3 Month Return | -20.77 % |
1 Year Return | -7.09 % |
Market Stats | |
Previous Close | ₹51.80 |
Open | ₹52.80 |
Volume | 5,476.00 |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹144.80Cr |
P/E Ratio | 0 |
PEG Ratio | 0 |
Market Cap | ₹144.80 Cr |
P/B Ratio | 0.98 |
EPS | 0 |
Dividend Yield | 0 |
Sector | Pharmaceuticals |
ROE | 3.74 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹144.80 Cr | 3.45% | 0.60 | NA | NA | |
NA | ₹10.17 Cr | 94.34% | 0.88 | NA | NA | |
NA | ₹261.26 Cr | 97.58% | 0.52 | ₹16 Cr | ₹108 Cr | |
NA | ₹122.53 Cr | 40.58% | 0.51 | NA | NA | |
NA | ₹14,909.73 Cr | -1.26% | 0.73 | ₹82 Cr | ₹1,465 Cr |
Organisation | Aarey Drugs & Pharmaceuticals Ltd |
Headquarters | |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for Aarey Drugs & Pharmaceuticals Ltd
Aarey Drugs & Pharmaceuticals Ltd's Debt Levels Not Problematic - 22 Mar, 2024
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Promoter Holding Up
Promoters have increased holdings from 45.28% to 45.44% in Sep 2024 quarter
Retail Holding Up
Retail Investor have increased holdings from 51.33% to 51.81% in Sep 2024 quarter
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 103.2% return, outperforming this stock by 105.0%
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 46.6% return, outperforming this stock by 54.1%
FII Holding Down
Foreign Institutions have decreased holdings from 3.40% to 2.75% in Sep 2024 quarter
Price Dip
In the last 3 months, AAREYDRUGS stock has moved down by -18.5%
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 45.44% | 0.36 | |
Foreign Institutions | 2.75% | ||
Mutual Funds | 0% | 0.00 | |
Retail Investors | 51.81% | 0.94 | |
Others | 0% | 0.00 |
Aarey Drugs & Pharmaceuticals Ltd’s net profit jumped 30.08% since last year same period to ₹1.60Cr in the Q2 2024-2025. On a quarterly growth basis, Aarey Drugs & Pharmaceuticals Ltd has generated 29.03% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending September 2018, Aarey Drugs & Pharmaceuticals Ltd has declared dividend of ₹0.10 - translating a dividend yield of 0.20%.
Read More about DividendsBearish
Neutral
Bullish
Aarey Drugs & Pharmaceuticals Ltd is currently in a Bearish trading position according to technical analysis indicators.
Aarey Drugs & Pharmaceuticals Ltd share price today stands at ₹50.82, Open. ₹52.8 ; Previous Close. ₹51.8 ; High. ₹52.98 ; Low. ₹49.51 ; 52 Week High. ₹74.8 ; 52 Week Low: ₹37.35.
Aarey Drugs & Pharmaceuticals Ltd is listed on NSE
Aarey Drugs & Pharmaceuticals Ltd is listed on BSE
Today’s traded volume of Aarey Drugs & Pharmaceuticals Ltd(AAREYDRUGS) is 5,476.00.
Today’s market capitalisation of Aarey Drugs & Pharmaceuticals Ltd(AAREYDRUGS) is ₹144.8Cr.
Aarey Drugs & Pharmaceuticals Ltd(AAREYDRUGS | Price |
---|---|
52 Week High | ₹74.8 |
52 Week Low | ₹37.35 |
Aarey Drugs & Pharmaceuticals Ltd(AAREYDRUGS) share price is ₹50.82. It is down -32.06% from its 52 Week High price of ₹74.8
Aarey Drugs & Pharmaceuticals Ltd(AAREYDRUGS) share price is ₹50.82. It is up 36.06% from its 52 Week Low price of ₹37.35
Aarey Drugs & Pharmaceuticals Ltd(AAREYDRUGS | Returns |
---|---|
1 Day Returns | -0.98% |
1 Month Returns | -10.59% |
3 Month Returns | -20.77% |
1 Year Returns | -7.09% |